Timing of erythropoiesis-stimulating agent initiation and adverse outcomes in nondialysis CKD: A propensity-matched observational study

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 5, 2010, Pages 882-888

  Seliger, Stephen ^a   Fox, Kathleen M ^b   Gandra, Shravanthi R ^c   Bradbury, Brian ^c   Van Hsu, Doren ^d   Walker, Loreen ^d   Chiou, Chiun Fang ^c   Fink, Jeffrey C ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Strategic Healthcare Solutions   (United States)

^c AMGEN INC   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; HEMOGLOBIN;

AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; RISK REDUCTION; TREATMENT OUTCOME;

AGED; AMBULATORY CARE; ANEMIA; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIESIS; FEMALE; HEMATINICS; HEMOGLOBINS; HOSPITALIZATION; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77952296240     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07171009     Document Type: Article

References (26)

1. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ: Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38: 955-962, 2001 (Pubitemid 32912694)
2. Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ: Kidney function and anemia as risk factors for coronary heart disease and mortality: The Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 151: 492-500, 2006 (Pubitemid 43144756)
3. Gerson A, Hwang W, Fiorenza J, Barth K, Kaskel F, Weiss L, Zelikovsky N, Fivush B, Furth S: Anemia and health-related quality of life in adolescents with chronic kidney disease. Am J Kidney Dis 44: 1017-1023, 2004
4. Goicoechea M, de Vinuesa SG, Gomez-Campdera F, Luno J: Predictive cardiovascular risk factors in patients with chronic kidney disease (CKD). Kidney Int Suppl 93: S35-S38, 2005 (Pubitemid 40019213)
5. Jurkovitz CT, Abramson JL, Vaccarino LV, Weintraub WS, McClellan WM: Association of high serum creatinine and anemia increases the risk of coronary events: Results from the prospective community-based Atherosclerosis Risk in Communities (ARIC) study. J Am Soc Nephrol 14: 2919-2925, 2003
6. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O: Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis 34: 125-134, 1999
7. Odden MC, Whooley MA, Shlipak MG: Association of chronic kidney disease and anemia with physical capacity: The Heart and Soul Study. J Am Soc Nephrol 15: 2908-2915, 2004
8. Perlman R, Finkelstein F, Liu L, Roys E: Quality of life in chronic kidney disease (CKD): A cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis 45: 658-666, 2005
9. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease, 2006. Am J Kidney Dis 47[Suppl 3]: S11-S145, 2006
10. The U.S. Recombinant Human Erythropoietin Predialysis Study: Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. The U.S. Recombinant Human Erythropoietin Predialysis Study Group. Am J Kidney Dis 18: 50-59, 1991
11. Leaf DE, Goldfarb DS: Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia. Kidney Int 75: 15-24, 2008
12. Fink J, Blahut S, Reddy M, Light P: Use of erythropoietin before the initiation of dialysis and its impact on mortality. Am J Kidney Dis 37: 348-355, 2001 (Pubitemid 32116028)
13. Xue JL, St Peter WL, Ebben JP, Everson SE, Collins AJ: Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. Am J Kidney Dis 40: 1153-1161, 2002 (Pubitemid 35403126)
14. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D; CHOIR Investigators: Correction of anemia with Epoetin alfa in chronic kidney disease. N Engl J Med 355: 2085-2098, 2006 (Pubitemid 44749317)
15. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; TREAT Investigators: A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361: 2019-2032, 2009
16. Cowper DC, Hynes DM, Kubal JD, Murphy PA: Using administrative databases for outcomes research: Select examples from VA Health Services Research and Development. J Med Syst 23: 249-259, 1999
17. Maynard C, Chapko MK: Data resources in the Department of Veterans Affairs. Diabetes Care 27[Suppl 2]: B22-B26, 2004 (Pubitemid 38569260)
18. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification: Part 4. Definition and classification of stages of chronic kidney disease. Am J Kidney Dis 39: S46, 2002
19. Levey AS, Greene T, Kusek J, Beck G: A simplified equation to predict glomerular filtration rate from serum creatinine (Abstract) J Am Soc Nephrol 11: 155A, 2000
20. Arnold N, Sohn N, Maynard C, Hynes D: VIREC Technical Report 2: VANDI Mortality Data Merge Project, Hines, IL, VA Information Resource Center, 2006
21. Rubin DB: Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127: 757-763, 1997
22. Drüeke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A; CREATE Investigators: Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355: 2071-2084, 2006 (Pubitemid 44749316)
23. Kurth T, Walker AM, Glynn RJ, Chan KA, Gaziano JM, Berger K, Robins JM: Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 163: 262-270, 2006 (Pubitemid 43145754)
24. Rubin DB: On principles for modeling propensity scores in medical research. Pharmacoepidemiol Drug Saf 13: 855-857, 2004
25. Steg PG, López-Sendón J, Lopez de Sa E, Goodman SG, Gore JM, Anderson FA Jr, Himbert D, Allegrone J, Van de Werf F; GRACE Investigators: External validity of clinical trials in acute myocardial infarction. Arch Intern Med 167: 68-73, 2007 (Pubitemid 46072409)
26. Rothwell PM: External validity of randomised controlled trials: "To whom do the results of this trial apply?" Lancet 365: 82, 2005